Short Interest in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Drops By 37.5%

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 500 shares, a decline of 37.5% from the February 28th total of 800 shares. Based on an average daily trading volume, of 2,700 shares, the short-interest ratio is presently 0.2 days. Currently, 0.1% of the company’s stock are sold short.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

Several hedge funds have recently bought and sold shares of FTXH. LPL Financial LLC lifted its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 9.3% in the fourth quarter. LPL Financial LLC now owns 55,876 shares of the company’s stock valued at $1,507,000 after buying an additional 4,776 shares in the last quarter. Envestnet Asset Management Inc. boosted its stake in First Trust Nasdaq Pharmaceuticals ETF by 17.0% during the 4th quarter. Envestnet Asset Management Inc. now owns 16,403 shares of the company’s stock valued at $442,000 after purchasing an additional 2,384 shares during the last quarter. Summit Investment Advisors Inc. boosted its stake in First Trust Nasdaq Pharmaceuticals ETF by 13.0% during the 4th quarter. Summit Investment Advisors Inc. now owns 14,173 shares of the company’s stock valued at $382,000 after purchasing an additional 1,633 shares during the last quarter. Finally, Vivaldi Capital Management LP increased its holdings in First Trust Nasdaq Pharmaceuticals ETF by 15.6% during the 4th quarter. Vivaldi Capital Management LP now owns 8,677 shares of the company’s stock worth $243,000 after purchasing an additional 1,171 shares in the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 0.9 %

FTXH stock traded up $0.26 during trading on Monday, reaching $27.53. 1,321 shares of the stock were exchanged, compared to its average volume of 3,797. First Trust Nasdaq Pharmaceuticals ETF has a twelve month low of $25.73 and a twelve month high of $29.72. The firm’s 50 day moving average is $27.82 and its 200 day moving average is $27.98. The firm has a market cap of $13.76 million, a P/E ratio of 21.02 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Thursday, March 27th will be given a dividend of $0.0992 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date of this dividend is Thursday, March 27th.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.